wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q34180815-5954B5CB-3F31-4735-AAA4-8939B4E5323C
Q34180815-5954B5CB-3F31-4735-AAA4-8939B4E5323C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34180815-5954B5CB-3F31-4735-AAA4-8939B4E5323C
A phase 2 trial of dacomitinib (PF-00299804), an oral, irreversible pan-HER (human epidermal growth factor receptor) inhibitor, in patients with advanced non-small cell lung cancer after failure of prior chemotherapy and erlotinib.
P921
Q34180815-5954B5CB-3F31-4735-AAA4-8939B4E5323C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34180815-5954B5CB-3F31-4735-AAA4-8939B4E5323C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
82630af7e1151e88e8ae34ab9d05aea66cb2f3b3
P921
chemotherapy